Research Article
MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
Table 3
Multivariate analysis of predictors associated with PCa and csPCa.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PCa, prostate cancer; csPCa, clinically significant prostate cancer; OR, Odds Ratio; CI, confidence interval; AUC, area under the receiver operating characteristics curve; PSA, prostate-specific antigen; f/t, free/total PSA ratio; PV, prostate volume; PSAD, PSA density; PSAV, PSA velocity; DRE, digital rectal examination; TRUS, transrectal ultrasound; mpMRI, multi-parametric magnetic resonance imaging. |